Why is Vaishali Pharma falling/rising?

As of 02-Jul, Vaishali Pharma Ltd's stock price is currently at 11.48, reflecting a decrease of 0.03, or 0.26%. The stock has underperformed its sector by 0.34% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 5.20%, and it has shown a significant year-to-date drop of 34.36%. Additionally, the company is facing challenges such as operating losses and a weak ability to service its debt, indicated by a poor EBIT to Interest ratio of 1.57. The stock's performance has been further hindered by a negative return on equity of 8.96%, and it has generated a return of -25.93% over the last year, which is compounded by a low earnings per share of Rs -1.64.
In the broader market context, while Vaishali Pharma's stock has struggled, the benchmark Sensex has seen a positive return of 7.65% year-to-date. This stark contrast highlights the company's below-par performance in both the short and long term, as it has underperformed the BSE500 over the past three years, one year, and three months. The falling investor participation, with a delivery volume decrease of 25.73% against the 5-day average, further indicates a lack of confidence among investors. Overall, the combination of weak fundamentals, negative operating profits, and underperformance relative to the market contributes to the stock's downward trajectory.